Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2Dermatologic 1

Conditions

Neoplasm Metastasis 2Meningioma 2Glioma 2Central Nervous System Vascular Malformations 2Aneurysm 2

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Laser Speckle Contrast Imaging × CNS × Clear all
NCT05305378 2024-08-07

Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow

Dynamic Light

Completed
8 enrolled
CNS

Aneurysm, Glioma, Meningioma, Neoplasm Metastasis, Central Nervous System Vascular Malformations

NCT05028400 2022-04-12

LSCI-NSURG

Insel Gruppe AG, University Hospital Bern

Phase NA Completed
20 enrolled
CNS

Aneurysm, Glioma, Meningioma, Neoplasm Metastasis, Central Nervous System Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡